Get started

Coronavirus (COVID-19)

INDONESIA COVID-19 - 2022 Brings a new waveWhile the trend is currently down, the rate of its decline is tapering off. This model also projects that by Jan 2022, Indonesia will see a next wave. This is suggested by the MACD histograms projected trajectory on the weekly chart. We check in again next month and see if it is following the trajectory drawn... Meanwhile, IF they are tracking this, it would be about time to do something. However, it seems that opening up for the next two months might be the Trojan Horse receipt.
C
by Auguraltrader
HGEN in EU Commission 10 Most Promising Treatments for COVID-19!European Commission’s independent experts selected Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19! CEO of Humanigen said today: "We look forward to continuing our discussions with colleagues at the European Medicines Agency to advance our efforts to submit a marketing authorization application for lenzilumab in COVID-19". In the same list you can see Pfizer, Roche, Astra Zeneca and Eli Lilly! Humanigen is the smallest company. Institutions loaded big on this dip of Humanigen, Inc. (HGEN), 132Mil in the last quarter! On 8/23/2021 Morgan Stanley reported an increased ownership in HGEN by +1,884.6%! Biggest shareholder is Blackrock with 3,037,693 shares worth $52.80Mil, which increased its position by +283.5% for a total ownership of 5.141% of Humanigen. So Blackrock paid an average of 17.3usd per share! The price of the stock is now 6.60usd! H.C. Wainwright’s Joseph Pantginis rates HGEN a Buy along with a $28 price target and said the market overreacted on that selloff. My price target is the 16.3usd resistance!
HLong
by TopgOptions
11
SINGAPORE COVID-19 Wave 3 Projection Update XIIIn a rather surprising, and significant turn of events, when revisiting the daily counts (which are grossly under reported as many are asked to stay home with primarily ART testing; only PCR positives are logged) there appears to be another kink in the trajectory. Earlier, the model projected a tapering of the numbers. This was also modelled in line with the experience of Malaysia, Indonesia, and even India. Two factors seemed to have not so relevant... the population density in built up areas in Singapore is much higher than any of these countries. Also, the measures imposed are rather different. And these two might be the crux of the kink, dragging along a sub wave, which in my humble opinion is probably a lot steeper, but appears less aggressive on the MACD histogram. Taking these into consideration, the model is projecting a longer run, with a less steeply rising histogrm. This would easily push the tapering off into December, if at all, else into 2022. Stay safe people... do decide to do what you think is necessary. Take very good care of yourself and especially of your family. Do take time to check into an earlier post at the end of June 2021... something was clearly indicated, and showed its face about a month later. Meanwhile, at that time, measures were relaxed and people got optimistic, perhaps a tad too early. Clearly, the model works, and this is yet again telling us something. We are still behind the curve.
C
by Auguraltrader
SINGAPORE COVID-19 Wave 3 Projection Update VIIIAt the present moment, in real life, there is a feel of relief. Some optimism that this can return to "new normal", with dining in reinstated on June 21. Thing is, according to the projections based on the trend analysis, a small spike is already on the way and June 21-30 is about the time is gets noticeably serious. Not so easy to get away when we are still behind the curve... Something we are missing, not yet seeing, and somewhere is brewing the next wave. Where is it???
C
by Auguraltrader
SINGAPORE COVID-19 Wave 3 Projection Update XI Been a while since, and much has happened... Now, the numbers are somewhat different as Singapore had decided to take a different stance, so bearing in mind that not every case is being tracked (by PCR) as a significant number is now being tested by default using the Antigen Rapid Test (ART) kits. Nonetheless, since October 10th, the spread is slowing slightly... and using the MACD histograms with whatever reliable data left, can roughly project a tapering down in mid-November. However, since the borders are reopening, combined with the massive handling and release from mandatory measures for reporting (stay home quarantine, ART testing, etc.)... we probably have a better idea early November (green circle) where this new dynamic will take us. So, the model here is now starting to have larger variations. IF you would kindly track back previous posts, you can see the projections are highly predictive, particularly a comment I made at the end of June, about somewhere is a leak and it is about to resurge. And lol, it did with a big bang into September October. Well... stay safe and well!
C
by Auguraltrader
1
$DIS: America's Sweetheart is WobblyLabor shortages, increased streaming competition, sub par content as of late. Will value investors step in and save it at 170 or is this a major crossroads in the future of this giant. The bullish case here mostly lies in whether or not inflation will persist. If we see the dollar continue to improve, value names may be on the table which will involve this getting snapped up. However, if inflation is persistent it may be a huge struggle to retain labor and could put a dent in streaming profits
NYSE:DIS
by Fox_Technicals
$MRK: Vaccine KrptoniteInvestors should continue to watch Merck and how it plays out here at the 80 level as their COVID drug treatment is pending approval. I believe the market is absolutely sleeping on the significance of this drug and the kind of impact it will have. A treatment is an absolute game changer provided the politics of COVID do not disrupt innovation, transparency and competition in the market. If Merck's drug is effective at treating COVID this will be disastrous to companies like MRNA, JNJ, DVAX, PFE and NVAX. Currently, we're still sitting at less than a 60% fully vaccinated population, the tightest labor supply in history and a work force petitioning vaccine mandates as was witnessed with Boeing workers in Seattle. This will force lawmakers hands to suspend vaccine mandates indefinitely crashing demand for vaccines in the future. The US population has made their stance and vaccine persuasion will only have a diminishing effect from here on out, so the only option is the option that works for everyone in order to minimize division in the country.
NYSE:MRKLong
by Fox_Technicals
Higher Time Frame Review of Dollar and Feds pumping of $ ***Yen is higher time frame bearish due to the way its central banking has set up its infrastructure*** that is all, will conduct regular weekly reviews and outlook. just wanted to jot down a refresher for myself as a mfer is busy af hope this helps anyone but you will need to be knowledgeable on: - intraday time frames - candle body closures - fundamental data - price action (action of price) - candle stick reading is basics you want to know before diving deeper in the sea of financial market
TVC:DXY
by KimboSlice04
COVID IN THE USA: REALITY IS A HARSH PLACETradingview has some amazing data on COVID. This chart is of importance for long term investment purposes (see fat disclaimer below). Importantly this is about total of all cases infections and deaths. Some may say that's meaningless. But there are important features on the chart. Say what you see! I'll say what I see. If the war on COVID was being won, one would expect to see at least clear plateaus. That makes sense because it means there is no massive set of new cases to increase the total. I hope folk get the point. Watch the red arrows. 1. On death total - it's accelerating. Certainly no plateau. 2. On case total - it's accelerating. No plateau. Of course this does not mean that the numbers won't plateau. The point is that the trajectories and the power of the numbers means they're not winning the war. A plateau would probably have been expected in the post-vaccination era. Some say, the plateau is coming soon. How would they know. Do they know the future better than everybody else? All I know is what I see: There are no plateaus. Do we stay with evidence or do we believe rhetoric repeated in lamestream media? Well, the choice is yours. Disclaimers : This is not advice or encouragement to trade securities on live accounts. Chart positions shown are not suggestions intended to assure you of an advantage. No predictions and no guarantees are supplied or implied. The author trades mostly trend following set ups which have a low win rate of approximately 40%. Heavy losses can be expected if trading live accounts. Any previous advantageous performance shown in other scenarios, is not indicative of future performance. If you make decisions based on opinion expressed here or on my profile and you lose your money, kindly sue yourself.
C
by Captain_Walker
4
Pharmaniaga - TP at 6 range possible?MYX:PHARMA With recent business deal signings will the punters back to this counter? From 2-3 days observation, personally this counter may still overlooked with addition of MCO 2.0 being introduced - the volume is just not there (yet?) Like it or not 14mils doses has been bought even some may decries the subpar 50%++ effective rate of Sinovac covid19 vaccine that being shared by certain country. The stock best performance was recorded last Aug, where the price hit 6.69 which is a handsome multiplier of the price prior to covid era averaging ~2 in last Jan-Feb *This is not a call sign - the writer can't confirm or deny any dealings related to this stock
MYX:PHARMA
by rontol
SINGAPORE COVID Wave 3 Projection Update XI Singapore just made the USA travel advisory list... and we have not yet even open borders. SG just need to first get its house in order, then dreams will work out. Anyways, I was having a chat about the astronomical numbers (by SG standards) and we looked at the charts. Then we projected where there might be peaking out. Knowing full well that in Indonesia and Malaysia, they saw a peak out after 2 months, with or without effective lockdowns. Collateral damage aside, the peak infected numbers levelled off, and we wonder when and at what levels Singapore would have hers. August is the chart take off, so October should be about right. Combined in our discussion, we applied Fibonacci extensions and Gann fan. Pinpointing a peaking out (levelling off in the cummulative charts) about 100,000-104,000 by mid October 2021. Here goes nothing! PS. Albert.. this one for our keeps. This is part our OUR SCRIPT. lolx
C
by Auguraltrader
£AZN 1-day classic patternsQ: What has the highest probability of occurring? After being one of the strongest performers in 2020 during the initial UK lockdown the stock lost over 30% of its value. In 2021 it has staged a modest recovery but is still over 15% below its all time high requiring an over 20% rally. There is well tested support at 8100p and resistance at 8775p. There is 2 classic patterns 1 that has not validated. 1 that has validated. The bull flag, with a breakout of 8775p, stop at 8100p, and projected target at 10150p. A risk-to-reward ratio of 2R. The breakout from the bull flag needs to be confirmed by a close outwith both the flag and resistance. A difficult task therefore requiring more time to confirmation. The double top, with a breakout of 8100p, and projected target at 7400p. Using a stop half the size of the range creates a 2R opportunity. The stock also pays a 2.48% dividend semi-annually. Given the length of the setup this trade may run deep into 2022 to allow that dividend to be collected. Although before that point there will be 2 earnings releases adding volatility to any potential positions held. The short trade is therefore not of interest here however considering it has validated this may act as a catalyst for the long side. But again it is not yet validated.
LSE:AZNLong
by xciiitradingco